Novavax, Inc.

/Novavax, Inc.

Novavax is a clinical-stage biotechnology company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Symbol

Last Closing Price
$1.65

Shares
30,000,000

Anticipated Date
TBD

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange